Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCUlpTOR stem cell trial for knee osteoarthritis
ACTRN12620000870954Phase 3Active, not recruiting
- Sponsor
- University of Sydney
- Start
- Mar 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Allogeneic mesenchymal stem cells with Placebo saline (2 arms). Primary endpoints: Patient-acceptable symptom state for knee pain and Central medial femorotibial cartilage thickness loss. Started Mar 2021; status: active, not recruiting.
02
Drugs
MSV alogénicas
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12620000870954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000870954.